Participation of group I p21-activated kinases in neuroplasticity

被引:23
|
作者
Koth, Andre P. [1 ]
Oliveira, Bruno R. [2 ]
Parfitt, Gustavo M. [1 ]
Buonocore, Juliana de Quadros [1 ]
Barros, Daniela M. [1 ]
机构
[1] Fundacao Univ Fed Rio Grande, ICB, Lab Neurociencias, Programa Posgrad Ciencias Fisiol, BR-96203900 Rio Grande, RS, Brazil
[2] Fundacao Univ Fed Rio Grande, ICB, Lab Biol Mol, Programa Posgrad Ciencias Fisiol, BR-96203900 Rio Grande, RS, Brazil
关键词
PAK; Erk; Signaling; Cytoskeleton; Neuroplasticity; Alzheimer's disease; Huntington's disease; REGULATES SPINE MORPHOGENESIS; LIGHT-CHAIN PHOSPHORYLATION; CENTRAL-NERVOUS-SYSTEM; NONMUSCLE MYOSIN-II; DENDRITIC SPINES; RHO-GTPASES; MOLECULAR-CLONING; SYNAPSE FORMATION; SMOOTH-MUSCLE; F-ACTIN;
D O I
10.1016/j.jphysparis.2014.08.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
PAKs are a family of serine/threonine protein kinases activated by small GTPases of the Rho family, including Rac and Cdc42, and are categorized into group I (isoforms 1, 2 and 3) and group II (isoforms 4, 5 and 6). PAK1 and PAK3 are critically involved in biological mechanisms associated with neurodevelopment, neuroplasticity and maturation of the nervous system, and changes in their activity have been detected in pathological disorders, such as Alzheimer's disease, Huntington's disease and mental retardation. The group I PAKs have been associated with neurological processes due to their involvement in intracellular mechanisms that result in molecular and cellular morphological alterations that promote cytoskeletal outgrowth, increasing the efficiency of synaptic transmission. Their substrates in these processes include other intracellular signaling molecules, such as Raf, Mek and LIMK, as well as other components of the cytoskeleton, such as MLC and FLNa. In this review, we describe the characteristics of group I PAKs, such as their molecular structure, mechanisms of activation and importance in the neurobiological processes involved in synaptic plasticity. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 50 条
  • [1] Group I p21-activated kinases in leukemia cell adhesion to fibronectin
    Kuzelova, Katerina
    Obr, Adam
    Roselova, Pavla
    Grebenova, Dana
    Otevrelova, Petra
    Brodska, Barbora
    Holoubek, Ales
    CELL ADHESION & MIGRATION, 2021, 15 (01) : 18 - 36
  • [2] Biology of the p21-activated kinases
    Bokoch, GM
    ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 : 743 - 781
  • [3] p21-activated kinases in cancer
    Rakesh Kumar
    Anupama E. Gururaj
    Christopher J. Barnes
    Nature Reviews Cancer, 2006, 6 : 459 - 471
  • [4] p21-activated kinases in cancer
    Kumar, Rakesh
    Gururaj, Anupama E.
    Barnes, Christopher J.
    NATURE REVIEWS CANCER, 2006, 6 (06) : 459 - 471
  • [5] Group I p21-activated kinases: Emerging roles in immune function and viral pathogenesis
    Pacheco, Almudena
    Chernoff, Jonathan
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (01): : 13 - 16
  • [6] Group Ⅱ p21-activated kinases as therapeutic targets in gastrointestinal cancer
    Yang-Guang Shao
    Ke Ning
    Feng Li
    World Journal of Gastroenterology, 2016, (03) : 1224 - 1235
  • [7] p21-activated kinases in human cancer
    Ratna K. Vadlamudi
    Rakesh Kumar
    Cancer and Metastasis Reviews, 2003, 22 : 385 - 393
  • [8] p21-Activated Kinases in Thyroid Cancer
    Bautista, Luis
    Knippler, Christina M.
    Ringel, Matthew D.
    ENDOCRINOLOGY, 2020, 161 (08)
  • [9] A novel regulator of p21-activated kinases
    Bagrodia, S
    Taylor, SJ
    Jordon, KA
    Van Aelst, L
    Cerione, RA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) : 23633 - 23636
  • [10] Inhibitors of p21-Activated Kinases (PAKs)
    Rudolph, Joachim
    Crawford, James J.
    Hoeflich, Klaus P.
    Wang, Weiru
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 111 - 129